<DOC>
	<DOCNO>NCT02611271</DOCNO>
	<brief_summary>Cytokine adsorption use cytosorb adsorber currently investigate reduce level proinflammatory cytokine patient severe sepsis septic shock . The adsorber frequently use series continuous renal replacement therapy . Up date , data removal antibiotic drug combine renal replacement therapy cytokine adsorptive therapy available . Therefore , want investigate - whether extent antibiotic drug ( piperacillin/tazobactam imipenem/cilastatin ) remove combined continuous renal replacement therapy cytosorb adsorption patient severe sepsis septic shock</brief_summary>
	<brief_title>Elimination Antibiotics During Renal Replacement Therapy Cytosorb Adsorptive Therapy</brief_title>
	<detailed_description>Patients trial undergoing renal replacement therapy part routine care . Thus , observational trial .</detailed_description>
	<mesh_term>Sepsis</mesh_term>
	<mesh_term>Acute Kidney Injury</mesh_term>
	<mesh_term>Critical Illness</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Tazobactam</mesh_term>
	<mesh_term>Piperacillin</mesh_term>
	<mesh_term>Piperacillin , tazobactam drug combination</mesh_term>
	<mesh_term>Antibiotics , Antitubercular</mesh_term>
	<mesh_term>Cilastatin</mesh_term>
	<criteria>Intensive care patient severe sepsis septic shock acute kidney injury require continuous renal replacement therapy cytokine adsorption Age &gt; 18 &lt; 18 Pregnancy Contraindications citrateanticoagulation continuous renal replacement therapy cytokine adsorption</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>